Cargando…

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer

Comprehensive transcriptome expression analyses of bladder cancer revealed distinct lncRNA clusters with differential molecular and clinical characteristics. In this study, pivotal lncRNAs were assessed for their impact on survival and their differential expression between the molecular bladder canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rinaldetti, Sebastien, Worst, Thomas Stefan, Rempel, Eugen, Kriegmair, Maximilian C., Hartmann, Arndt, Porubsky, Stefan, Bolenz, Christian, Erben, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687888/ https://www.ncbi.nlm.nih.gov/pubmed/33235218 http://dx.doi.org/10.1038/s41598-020-77252-2

Ejemplares similares

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
por: Rinaldetti, Sebastien, et al.
Publicado: (2017)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer
por: Wu, Sheng, et al.
Publicado: (2020)

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors
por: Ali, Nairveen, et al.
Publicado: (2021)

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
por: Kriegmair, M.C., et al.
Publicado: (2018)

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data
por: Wu, Sheng, et al.
Publicado: (2019)

Re: “Multiparametric cystoscopy: opportunities to enhance bladder cancer detection”
por: Kriegmair, Maximilian Christian, et al.
Publicado: (2020)

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
por: Worst, Thomas S., et al.
Publicado: (2018)

IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status
por: Worst, Thomas S., et al.
Publicado: (2014)

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
por: Eckstein, Markus, et al.
Publicado: (2018)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
por: Breyer, Johannes, et al.
Publicado: (2017)

KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Jütte, Hendrik, et al.
Publicado: (2021)

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
por: Breyer, Johannes, et al.
Publicado: (2023)

Disulfidptosis-associated lncRNAs predict breast cancer subtypes
por: Xia, Qing, et al.
Publicado: (2023)

A Novel Assessment Model Based on Molecular Subtypes of Hypoxia-Related LncRNAs for Prognosis of Bladder Cancer
por: Chen, Xianwu, et al.
Publicado: (2021)

Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients
por: Luo, Junhua, et al.
Publicado: (2021)

Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes
por: Mathias, Carolina, et al.
Publicado: (2021)

Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
por: Bolenz, Christian, et al.
Publicado: (2018)

Decoding LncRNAs
por: Borkiewicz, Lidia, et al.
Publicado: (2021)

Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015)

Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy
por: Xiao, Ying, et al.
Publicado: (2022)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022)

Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: Chen, Fei, et al.
Publicado: (2022)

Uncovering the roles of microRNAs/lncRNAs in characterising breast cancer subtypes and prognosis
por: Li, Xiaomei, et al.
Publicado: (2021)

Identification of pivotal lncRNAs in papillary thyroid cancer using lncRNA–mRNA–miRNA ceRNA network analysis
por: Liang, Weiwei, et al.
Publicado: (2019)

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Functions and properties of nuclear lncRNAs—from systematically mapping the interactomes of lncRNAs
por: Guh, Chia-Yu, et al.
Publicado: (2020)

A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer
por: Uysal, Daniel, et al.
Publicado: (2021)

LncRNAs act as prognostic biomarkers in bladder carcinoma: A meta-analysis
por: Zhong, Yucheng, et al.
Publicado: (2019)

Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer
por: Lia, Thongher, et al.
Publicado: (2022)

Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer
por: Lu, Zechao, et al.
Publicado: (2022)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
por: Lin, Hongsheng, et al.
Publicado: (2021)

Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2022)

Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

LncRNAs in Stem Cells
por: Hu, Shanshan, et al.
Publicado: (2016)

LncRNAs in pancreatic cancer
por: Huang, Xiaoyi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ir1k9degqjk6acf2pi9ps5cn43